House Bill 2020
2023-2024 Regular Session
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.
Co-Sponsorship Memo
Prime Sponsor
Representative Frank Burns
D House District 72
Co-Sponsors
Rep. Jose Giral
D House District 180
Rep. Christina Sappey
D House District 158
Rep. Johanny Cepeda-Freytiz
D House District 129
Rep. G. Roni Green
D House District 190
Bill Status & History
Last Action: Referred to Judiciary, Feb. 7, 2024
House
H
S
Printers Numbers
Votes
There are no votes available.
Committee Meetings
There are no committee meetings available.
Statute References
This bill amends the act of April 14, 1972 (P.L.0233, No.64), known as the Controlled Substance, Drug, Device And Cosmetic Act, The. Other bills amending the same statute are listed below.
Rep. Carol Hill-Evans
D House District 95
Rep. Doyle Heffley
R House District 122
Rep. Sara Innamorato
D House District 21
Only the first 5 bills are included here. Looking for more?
View all legislation amending the act of
April 14, 1972 (P.L.0233, No.64), known as the Controlled Substance, Drug, Device And Cosmetic Act, The - opens in a new tab
House Bill 2020
2023-2024 Regular Session
Sponsors
BURNS, GIRAL, SAPPEY, CEPEDA-FREYTIZ, GREEN
Short Title
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.
Memo Subject
Syringe Services Program Legislation to Reduce Overdose Deaths and Disease Transmission and Increase Connections to Care
Actions
| 2583 | Referred to JUDICIARY, Feb. 7, 2024 |
Generated 09/16/2024 04:20 PM